Cargando…
Epstein–Barr virus and multiple sclerosis: potential opportunities for immunotherapy
Multiple sclerosis (MS) is a common chronic inflammatory demyelinating disease of the central nervous system (CNS) causing progressive disability. Many observations implicate Epstein–Barr virus (EBV) in the pathogenesis of MS, namely universal EBV seropositivity, high anti-EBV antibody levels, alter...
Autores principales: | Pender, Michael P, Burrows, Scott R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237030/ https://www.ncbi.nlm.nih.gov/pubmed/25505955 http://dx.doi.org/10.1038/cti.2014.25 |
Ejemplares similares
-
Epstein–Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis
por: Pender, Michael P, et al.
Publicado: (2014) -
Defective T-cell control of Epstein–Barr virus infection in multiple
sclerosis
por: Pender, Michael P, et al.
Publicado: (2017) -
Defective T-cell control of Epstein–Barr virus infection in multiple sclerosis
por: Pender, Michael P, et al.
Publicado: (2017) -
Epstein–Barr Virus in Multiple Sclerosis: Theory and Emerging Immunotherapies
por: Bar-Or, Amit, et al.
Publicado: (2020) -
The Essential Role of Epstein-Barr Virus in the Pathogenesis of Multiple Sclerosis
por: Pender, Michael P.
Publicado: (2011)